DWTX READ THE FULL DWTX RESEARCH REPORT Business Update 100 Patients Enrolled in Phase 2b Trial of Halneuron®; Interim ...

A new study reveals the structural mechanisms of TRPM3 activation by heat and ligands, providing insights for the development ...

You finally got your hands on a new novel you’ve been wanting to read. You’re turning the crisp paper of the pages when suddenly you get a paper cut. Pain erupts on your finger. A discomfiting ...

Monash University scientists have developed a new (preclinical) method to distinguish between chronic pain subtypes, such as fibromyalgia and peripheral neuropathy. Chronic pain is globally prevalent ...

On March 18, 2025, Dogwood Therapeutics, Inc. (NASDAQ:DWTX) announced that the first patient was dosed in the Phase 2b HALT-CINP (Halneuron Treatment of Chemotherapy-Induced Neuropathic Pain) trial.

Around eight out of 10 children survive their cancer for 10 years or more, but more than half of them report delayed and ongoing pain in adulthood. Around eight out of 10 children survive their cancer ...

Not revised: This Reviewed Preprint includes the authors’ original preprint (without revision), an eLife assessment, and public reviews. In the presented study, the authors aim to explore the role of ...

The following is a summary of “Slow depolarizing electrical stimuli reveal differential time courses of nociceptor recovery after prolonged topical capsaicin in human skin,” published in the September ...